Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V36419 | (Lys(Biotin)29)-Cortistatin-29 (human) | (Lys(Biotin)29)-Cortistatin-29 (human) is a peptide compound. | |
|
|
V36667 | (Lys(Et)33)-Thymopoietin I/II (32-36) (bovine) | (Lys(Et)33)-Thymopoietin I/II (32-36) (bovine) is a peptide compound. | |
|
|
V36649 | (Lys18)-Pseudin-2 | (Lys18)-Pseudin-2 is a peptide compound. | |
|
V34917 | (Lys3)-Bombesin | 66839-66-5 | [Lys3]-Bombesin is a biologically active peptide. |
|
V36703 | (Lys7)-Dermorphin | 142689-18-7 | (Lys7)-Dermorphin is a peptide compound. |
|
V36409 | (Lys8)-Conopressin S | 130836-26-9 | (Lys8)-Conopressin S is a peptide compound. |
|
V36892 | (Lys8,Lys9)-Neurotensin (8-13) | 139026-64-5 | [Lys8, Lys9]-Neurotensin (8-13) (JMV438) is an analog of neurotensin that acts by activating G protein-coupled receptors NTS1 and NTS2. |
|
|
V36893 | (Lys9,Trp11,Glu12)-Neurotensin (8-13) (Cyclic Analog) | (Lys9,Trp11,Glu12)-Neurotensin (8-13) (Cyclic Analog) is a peptide compound. | |
|
V36803 | (Met(O)27)-Glucagon (1-29) (human, rat, porcine) | 75217-63-9 | (Met(O)27)-Glucagon (1-29) (human, rat, porcine) is a glucagons and glucagon-Like peptide (GLP-1 / GLP-2) acting as a GLP agonist with antidiabetic potential. |
|
V36748 | (Met(O)5)-Enkephalin | 60283-51-4 | (Met(O)5)-Enkephalin is a peptide compound. |
|
|
V36697 | (Met2)-Deltorphin | (Met2)-Deltorphin is a peptide compound. | |
|
|
V36836 | (Met5,Pro6,D-Phe7,D-Trp9,Phe10)-α-MSH (5-13) | (Met5,Pro6,D-Phe7,D-Trp9,Phe10)-α-MSH (5-13) is a peptide compound. | |
|
|
V37047 | (N-ME-D-PHE6,D-TRP7,9,LEU10-(R)-LEU11)-SUBSTANCE P (6-11) | (N-ME-D-PHE6,D-TRP7,9,LEU10-(R)-LEU11)-SUBSTANCE P (6-11) is a peptide compound. | |
|
V37090 | (N-Me-Phe3,D-Pro4)-β-Casomorphin (1-4) amide (bovine) | 83397-56-2 | PL-017 is a potent, selective μ opioid receptor agonist (activator) with IC50 of 5.5 nM for 125I-FK 33,824 binding to the μ site. |
|
V36709 | (N-Me-Tyr1,N-Me-Arg7,D-Leu-NHEt8)-Dynorphin A (1-8) | 103613-84-9 | (N-Me-Tyr1,N-Me-Arg7,D-Leu-NHEt8)-Dynorphin A (1-8) (E-2078) is a stable Dynorphin A (1-8) similar It is a kappa opioid receptor (KOR) agonist. |
|
V36589 | (Nle13,Glu14)-Motilin (human, porcine) | 50881-15-7 | (Nle13,Glu14)-Motilin (human, porcine) is a peptide compound. |
|
V36462 | (Nle27)-GRF (1-29) amide (human) | 91869-58-8 | (Nle27)-GRF (1-29) amide (human) is a peptide compound. |
|
V36831 | (Nle4)-α-MSH | 64887-70-3 | (Nle4)-α-MSH is a synthetic analog of melanocyte-stimulating hormone α-MSH. |
|
V36653 | (Nle6)-Sarafotoxin C | 352283-69-3 | (Nle6)-Sarafotoxin C is a peptide compound. |
|
V36949 | (Nle8·18,Tyr34)-pTH (1-34) (human) | 78041-34-6 | (Nle8,18,Tyr34)-pTH (1-34) (human) is a bioactive peptide discovered by peptide screening. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
